scispace - formally typeset
H

Howard Lesiuk

Researcher at University of Ottawa

Publications -  75
Citations -  6936

Howard Lesiuk is an academic researcher from University of Ottawa. The author has contributed to research in topics: Aneurysm & Subarachnoid hemorrhage. The author has an hindex of 31, co-authored 66 publications receiving 6118 citations. Previous affiliations of Howard Lesiuk include Ottawa Hospital & University of British Columbia.

Papers
More filters
Journal ArticleDOI

The Canadian CT Head Rule for patients with minor head injury.

TL;DR: The Canadian CT Head Rule is developed, a highly sensitive clinical decision rule for use of CT that has the potential to significantly standardise and improve the emergency management of patients with minor head injury.
Journal ArticleDOI

The Canadian C-spine Rule for radiography in alert and stable trauma patients

TL;DR: The Canadian C-Spine Rule is derived, a highly sensitive decision rule that will allow emergency department (ED) physicians to be more selective in use of radiography in alert and stable trauma patients and has the potential to significantly reduce practice variation and inefficiency in ED use of C-spine radiography.
Journal ArticleDOI

The Canadian C-Spine Rule versus the NEXUS Low-Risk Criteria in Patients with Trauma

TL;DR: For alert patients with trauma who are in stable condition, the CCR is superior to the NLC with respect to sensitivity and specificity for cervical-spine injury, and its use would result in reduced rates of radiography.
Journal ArticleDOI

Comparison of the Canadian CT Head Rule and the New Orleans Criteria in Patients With Minor Head Injury

TL;DR: For patients with minor head injury and GCS score of 15, the Canadian CT Head Rule and the NOC have equivalent high sensitivities for need for neurosurgical intervention and clinically important brain injury, but the CCHR has higher specificity for important clinical outcomes than does the N OC, and its use may result in reduced imaging rates.
Journal ArticleDOI

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.

Michael D. Hill, +776 more
- 14 Mar 2020 - 
TL;DR: Nerinetide did not improve the proportion of patients achieving good clinical outcomes after endovascular thrombectomy compared with patients receiving placebo, and this trial is registered with ClinicalTrials.gov, NCT02930018.